Seaview Investment Managers’s VanEck Pharmaceutical ETF PPH Stock Holding History

Seaview Investment Managers’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,240	Closed	-$2.11M	–	112
2024 Q3	$2.11M	Buy	+22,240	New	+$2.11M	0.64%	40
2023 Q2	–	Sell	-26,298	Closed	-$2.04M	–	116
2023 Q1	$2.04M	Sell	26,298 -147	-0.6%	-$11.3K	0.7%	43
2022 Q4	$2.06M	Sell	26,445 -301	-1%	-$22.2K	0.82%	41
2022 Q3	$1.8M	Buy	26,746 +3,114	+13%	+$229K	0.73%	42
2022 Q2	$1.82M	Buy	23,632 +322	+1%	+$25.1K	0.82%	35
2022 Q1	$1.86M	Buy	+23,310	New	+$1.78M	0.62%	46

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Seaview Investment Managers's PPH Position: Q4 2024 in Review

Seaview Investment Managers sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 22,240 shares — an estimated $2.11M sold.

Seaview Investment Managers first reported a position in PPH in Q1 2022 and held it in 6 quarters. The position peaked at $2.11M in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

Seaview Investment Managers reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
Seaview Investment Managers sold 22,240 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $2.11M.
Seaview Investment Managers first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and held it in 6 quarters.
Seaview Investment Managers's VanEck Pharmaceutical ETF position peaked at $2.11M in Q3 2024.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Seaview Investment Managers's 13F filing for Q4 2024, filed 13 Feb 2025.